US Patent 8778880 Human growth hormone modified at position 35
Patent 8778880 was granted and assigned to Ambrx on July, 2014 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 8778880 Human growth hormone modified at position 35
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
